✦ LIBER ✦

Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study

✍ Scribed by M. TAKANO; T. SUGIYAMA; N. YAEGASHI; M. SAKUMA; M. SUZUKI; Y. SAGA; K. KUZUYA; J. KIGAWA; M. SHIMADA; H. TSUDA; T. MORIYA; A. YOSHIZAKI; T. KITA; Y. KIKUCHI

Book ID: 109086363
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 115 KB
Volume: 18
Category: Article
ISSN: 1048-891X
DOI: 10.1111/j.1525-1438.2007.01158.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EXPERIENCE OF COMBINATION THERAPY WITH B

EXPERIENCE OF COMBINATION THERAPY WITH BEVACIZUMAB FOR RECURRENT/REFRACTORY CLEAR CELL CARCINOMA OF THE OVARY

✍ M. Takano; Y. Kikuchi; T. Kita; K. Kudoh; M. Kato; T. Yoshikawa; M. Miyamoto; A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 58 KB

A retrospective study of second-line che

A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum

✍ Kentaro Yamazaki; Shuichi Hironaka; Narikazu Boku; Hirofumi Yasui; Akira Fukutom 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 248 KB

Second-line combination chemotherapy wit

Second-line combination chemotherapy with docetaxel and nedaplatin for metastatic or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus cisplatin

✍ Ryohei Kawabata; Hiroshi Imamura; Tomono Kishimoto; Shinji Kitamura; Yoshimi Hac 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 205 KB